Last reviewed · How we verify
NCT06810388
Impact of Family-Centered Empowerment on Caregivers of Children With Cancer: A Quasi-Experimental Study Protocol
NA trial testing Health education intervention program based on a family-centered empowerment model in Malignant Tumor in 128 participants. Not yet recruiting.
1 July 2026
Quick facts
| Lead sponsor | Xiaowan Li |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 128 |
| Start date | 1 July 2025 |
| Primary completion | 1 July 2026 |
| Estimated completion | 1 July 2026 |
Drugs / interventions tested
- Health education intervention program based on a family-centered empowerment model
- Implementation of routine care measures
Conditions studied
- Malignant Tumor — all drugs for Malignant Tumor →
Sponsor
Xiaowan Li
Who can join
18 and older, any sex, with Malignant Tumor. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this trial is to understand the impact of a family empowerment-based intervention program on family caregivers' readiness to care and ability to care. It aims to elucidate whether a health education intervention program based on the Family Empowerment Model improves family caregivers' readiness for care and ability to care. Participants will receive a health education program based on the family empowerment model and will complete questionnaires three days prior to admission, during hospitalization, and three days prior to discharge.This study is a non-pharmacological intervention and will not involve any changes in treatment or chemotherapy regimens.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of a Family-Centered Empowerment Model-Based Intervention on the Caregiving Capacity and Preparedness of Caregivers of Children With Malignant Neoplasms: Protocol for a Quasi-Experimental Study.
Li X, Yang Y, Chen Q, Ma J, et al · · 2025 · PMID 40729689 · DOI 10.2196/73304
Verify or expand the search:
- PubMed search for NCT06810388
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Malignant Tumor
Currently open trials in the same condition.
- NCT07193329 — Psychological Distress in Malignant Tumor Patients: Effects on Treatment Adherence, Outcomes, and Quality of Life · recruiting
- NCT06618274 — Effectiveness of Central Oncology Navigation and the Use of an ORN · NA · recruiting
- NCT06674889 — Rehabilitation Outcomes Study · NA · recruiting
- NCT05862259 — A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies · recruiting
- NCT05596344 — Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06810388 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xiaowan Li
- Last refreshed: 5 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06810388.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing